BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility.
With the investment, the company will produce hundreds of millions of additional units of prefilled flush syringes annually to meet growing hospital demand, according to an Aug. 4 company news release.
These syringes are used as part of catheter care and maintenance to prevent catheter-related complications. They are manufactured using a fully automated, hands-free process that allows clinicians to be the first person to touch the syringe, thus reducing the potential for contamination.
Over the past three years, BD has invested more than $80 million to expand its manufacturing capacity and increased U.S. production by more than 740 million units.
BD — also called Becton, Dickinson and Company — is a Franklin Lakes, N.J.-based company that operates more than 30 manufacturing and distribution facilities across 17 states and Puerto Rico.
